Studies on the relation between the pineal and human puberty have yielded conflicting results, partly due to methodologic issues, such as failure to consider the characteristic secretory rhythm of melatonin, or exclusion of normal subjects. Melatonin nocturnal rhythm was assessed in 62 normal subjects (ages 5–17 years), in whom hourly blood samples were collected by constant withdrawal from 18.00 to 08.00 h. Melatonin peak and mean integrated nocturnal concentrations were highly correlated (r = 0.90, p < 0.05) and data are shown for melatonin peak. Tanner criteria were applied for pubertal stages. Mean melatonin peak was 153.6 ± 72.6 pg/ml for stage 1, 141.0 ± 26.2 pg/ml for stage 2, and 116.6 ± 43.6 pg/ml for stages 3–5. There was a significant linear trend for decreasing melatonin peak with puberty. The subjects were also grouped into discrete age groups (5–6.99 years through 15–17 years); a significant linear trend was present for decreasing melatonin peak with age. The correlation between melatonin peak and age for all cases was r = –0.29, p < 0.05. Analysis of covariance for melatonin peak among the pubertal groups showed no relation of melatonin and puberty when age was covaried. The time of peak was not significantly different among the pubertal groups or the age groups, despite a significant linear trend for later bedtime with age. The duration of the nocturnal surge was not significantly different among the pubertal groups. The data suggest that an overlapping effect of age may mask an interaction between the pineal and normal human puberty.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.